Thomas DC - Search Results

1

Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Han D, Thomas DC, Zager JS, Pockaj B, White RL, Leong SP. Han D, et al. Among authors: thomas dc. World J Clin Oncol. 2016 Apr 10;7(2):174-88. doi: 10.5306/wjco.v7.i2.174. World J Clin Oncol. 2016. PMID: 27081640 Free PMC article. Review.

2

Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival.

Thomas DC, Han G, Leong SP, Kashani-Sabet M, Vetto J, Pockaj B, White RL, Faries MB, Schneebaum S, Mozzillo N, Charney KJ, Sondak VK, Messina JL, Zager JS, Han D. Thomas DC, et al. Ann Surg Oncol. 2019 Jul;26(7):2254-2262. doi: 10.1245/s10434-019-07369-w. Epub 2019 Apr 22. Ann Surg Oncol. 2019. PMID: 31011906

3

ASO Author Reflections: Recurrence of Melanoma After a Negative Sentinel Node Biopsy-Predictors and Impact of Recurrence Site on Survival.

Thomas DC, Han D. Thomas DC, et al. Ann Surg Oncol. 2019 Dec;26(Suppl 3):756-757. doi: 10.1245/s10434-019-07889-5. Epub 2019 Sep 30. Ann Surg Oncol. 2019. PMID: 31571053 No abstract available.

4

Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery.

Salazar MC, Rosen JE, Wang Z, Arnold BN, Thomas DC, Herbst RS, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Salazar MC, et al. Among authors: thomas dc. JAMA Oncol. 2017 May 1;3(5):610-619. doi: 10.1001/jamaoncol.2016.5829. JAMA Oncol. 2017. PMID: 28056112 Free PMC article.

5

Adjuvant immunotherapy for melanoma.

Thomas D, Bello DM. Thomas D, et al. J Surg Oncol. 2021 Mar;123(3):789-797. doi: 10.1002/jso.26329. J Surg Oncol. 2021. PMID: 33595889 Review.

6

Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery.

Thomas DC, Arnold BN, Rosen JE, Salazar MC, Blasberg JD, Detterbeck FC, Boffa DJ, Kim AW. Thomas DC, et al. Lung Cancer. 2017 Jan;103:75-81. doi: 10.1016/j.lungcan.2016.11.016. Epub 2016 Nov 28. Lung Cancer. 2017. PMID: 28024700

7

The Significance of Upfront Knowledge of N2 Disease in Non-small Cell Lung Cancer.

Thomas DC, Arnold BN, Rosen JE, Salazar MC, Detterbeck FC, Blasberg JD, Boffa DJ, Kim AW. Thomas DC, et al. World J Surg. 2018 Jan;42(1):161-171. doi: 10.1007/s00268-017-4165-6. World J Surg. 2018. PMID: 28799084

8

Adjuvant Chemotherapy for T3 Non-Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe.

Salazar MC, Rosen JE, Arnold BN, Thomas DC, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Salazar MC, et al. Among authors: thomas dc. J Thorac Oncol. 2016 Jul;11(7):1090-100. doi: 10.1016/j.jtho.2016.03.009. Epub 2016 Mar 21. J Thorac Oncol. 2016. PMID: 27013407 Free article.

9

Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.

Graff-Baker A, Roman SA, Thomas DC, Udelsman R, Sosa JA. Graff-Baker A, et al. Among authors: thomas dc. Surgery. 2009 Dec;146(6):1105-15. doi: 10.1016/j.surg.2009.09.020. Surgery. 2009. PMID: 19958938

10

Minimally Invasive Approaches to Pediatric Solid Tumors.

Christison-Lagay ER, Thomas D. Christison-Lagay ER, et al. Surg Oncol Clin N Am. 2019 Jan;28(1):129-146. doi: 10.1016/j.soc.2018.07.005. Epub 2018 Oct 23. Surg Oncol Clin N Am. 2019. PMID: 30414678 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

522 results

Search Page